Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PROCEPT BioRobotics Corporation - Common Stock
(NQ:
PRCT
)
23.63
-4.21 (-15.12%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PROCEPT BioRobotics Corporation - Common Stock
< Previous
1
2
3
4
5
6
Next >
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
July 14, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
April 29, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Where PROCEPT BioRobotics Stands With Analysts
↗
April 25, 2025
Via
Benzinga
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
April 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Earnings Scheduled For April 24, 2025
↗
April 24, 2025
Via
Benzinga
4 Analysts Assess PROCEPT BioRobotics: What You Need To Know
↗
February 26, 2025
Via
Benzinga
Earnings Scheduled For February 25, 2025
↗
February 25, 2025
Via
Benzinga
How Is The Market Feeling About PROCEPT BioRobotics?
↗
January 24, 2025
Via
Benzinga
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
April 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
April 10, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
March 24, 2025
Aquablation therapy delivers similar symptom score reduction, superior ejaculatory function preservation, and superior continence preservation to laser enucleation in 80–180 mL prostates in a...
From
PROCEPT BioRobotics
Via
GlobeNewswire
5 Analysts Assess PROCEPT BioRobotics: What You Need To Know
↗
December 02, 2024
Via
Benzinga
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
March 14, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results
February 25, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
February 07, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Looking Into PROCEPT BioRobotics's Recent Short Interest
↗
November 14, 2024
Via
Benzinga
The Analyst Landscape: 6 Takes On PROCEPT BioRobotics
↗
November 14, 2024
Via
Benzinga
PROCEPT BioRobotics's Earnings Outlook
↗
October 25, 2024
Via
Benzinga
Spruce Point Sees Trouble Ahead For Procept BioRobotics
↗
January 16, 2025
Spruce Point Capital warns of Procept BioRobotics' overstated market potential and growth claims, citing niche product limitations and valuation risks.
Via
Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
↗
December 02, 2024
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via
Benzinga
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
December 02, 2024
Via
Benzinga
PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
November 26, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
↗
November 03, 2024
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).
Via
Benzinga
PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock
October 29, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Royal Caribbean Sails Onto The IBD 50: Build Your List Of Stocks To Watch With These Top IBD Screens
↗
October 28, 2024
Royal Caribbean earns its spot on the Big Cap 20 with a best-possible 99 Composite Rating, putting it in the top 1% of all stocks.
Via
Investor's Business Daily
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
October 28, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential
↗
October 28, 2024
PROCEPT BioRobotics stock gains as Q3 earnings beat estimates with revenue up 66% YoY, driven by strong system sales and consumable revenue growth.
Via
Benzinga
Topics
Earnings
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
↗
October 28, 2024
Via
Benzinga
Procept Biorobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise
↗
October 28, 2024
The company sells systems that perform aquablation to treat enlarged prostates.
Via
Investor's Business Daily
PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
October 28, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
